Dexcom share price today

(DXCM)

Dexcom share price is $80.24 & ₹6,863.57 as on 30 Dec 2024, 20.31 hrs IST

$80.24

▲

-0.33

(-0.41%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Dexcom share price in Dollar and Rupees. Guide to invest in Dexcom from India. Also see the sentimental analysis on Indian investors investing in Dexcom. Get details on the Indian mutual funds that are investing in Dexcom. Get Analyst recommendations and forecasts along with all the Dexcom's financials.

Dexcom share price movements

Today's Low: $79.64
Today's High: $80.46
$80.24
0.75%
Downside
Day's Volatility :1.02%
Upside
0.27%
52 Weeks Low: $62.34
52 Weeks High: $142.00
$80.24
22.31%
Downside
52 Weeks Volatility :56.1%
Upside
43.49%

Dexcom Returns

Period	Dexcom, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	19.69%	-9.8%	0.0%
6 Months	-28.47%	-4.7%	0.0%
1 Year	-34.81%	1.9%	0.0%
3 Years	-40.23%	-1.8%	-21.3%

Dexcom Key Statistics

in dollars & INR

Previous Close	$80.24
Open	$80.03
Today's High	$80.46
Today's Low	$77.8
Market Capitalization	$31.3B
Today's Volume	$1.7M
52 Week High	$142.0
52 Week Low	$62.34
Revenue TTM	$4.0B
EBITDA	$840.4M
Earnings Per Share (EPS)	$1.65
PE Ratio	48.63
Profit Margin	17.22%
Quarterly Earnings Growth YOY	0.16%
Return On Equity TTM	32.06%

How to invest in Dexcom from India?

It is very easy for Indian residents to invest directly in Dexcom from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dexcom stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dexcom or DXCM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dexcom or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dexcom shares which would translate to 0.011 fractional shares of Dexcom as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dexcom, in just a few clicks!

Returns in Dexcom for Indian investors in Rupees

Investment Value

₹1,00,000

Dexcom investment value today

Current value as on today

₹67,983

Returns

₹32,017

(-32.02%)

Returns from Dexcom Stock

₹34,812 (-34.81%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Dexcom

27%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Dexcom on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 27% more investors are searching Dexcom in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Dexcom

Name	Shares Held	Change in Shares	% of Assets
ICICI Prudential NASDAQ 100 Index Fund Direct Growth	5146	0.00	0.20%
Motilal Oswal S&P 500 Index Fund Direct Growth	3444	7.85	0.06%

Global Institutional Holdings in Dexcom

Vanguard Group Inc
12.14%
BlackRock Inc
8.84%
Capital Research Global Investors
4.60%
State Street Corp
4.27%
Baillie Gifford & Co Limited.
3.84%
Sands Capital Management, LLC
2.64%

Analyst Recommendation on Dexcom

Buy

86%Buy

13%Hold

0%Sell

Based on 30 Wall street analysts offering stock ratings for Dexcom(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Dexcom

What analysts predicted

Upside of 19.97%

Current:

$80.24

Target:

$96.26

Insights on Dexcom

Price Movement
In the last 1 month, DXCM stock has moved up by 2.9%
Decreasing Revenue
Dexcom, Inc. has experienced a decline in revenue over the last two quarters, dropping from $1.00 billion to $994.2 million. This represents an average decrease of 1.0% per quarter.
Decreasing Net Profit
Dexcom, Inc. has seen a decline in its net profit over the last four quarters, dropping from $256.3 million to $134.6 million. This represents an average decrease of 17.0% in net profit each quarter.
DXCM vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 56.8% return, outperforming this stock by 92.1%
DXCM vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 110.9% return, outperforming this stock by 151.6%
Price to Sales
Dexcom, Inc. has a Price-to-Sales Ratio of 8.0, meaning that investors are willing to pay $8.00 for every $1.00 of sales the company generates. In comparison, Boston Scientific Corp. has a slightly higher Price-to-Sales Ratio of 8.4, indicating that investors are willing to pay a bit more for each dollar of sales from that company.

Dexcom Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.0B	↑ 43.58%
Net Income	$-127.1M	↑ 153.19%
Net Profit Margin	-12.32%	↓ 5.33%

	FY19	Y/Y Change
Revenue	$1.5B	↑ 43.08%
Net Income	$101.1M	↓ 179.54%
Net Profit Margin	6.85%	↑ 19.17%

	FY20	Y/Y Change
Revenue	$1.9B	↑ 30.54%
Net Income	$493.6M	↑ 388.23%
Net Profit Margin	25.62%	↑ 18.77%

	FY21	Y/Y Change
Revenue	$2.4B	↑ 27.08%
Net Income	$154.7M	↓ 68.66%
Net Profit Margin	6.32%	↓ 19.3%

	FY22	Y/Y Change
Revenue	$2.9B	↑ 18.84%
Net Income	$341.2M	↑ 120.56%
Net Profit Margin	11.73%	↑ 5.41%

	FY23	Y/Y Change
Revenue	$3.6B	↑ 24.49%
Net Income	$541.5M	↑ 58.7%
Net Profit Margin	14.95%	↑ 3.22%

	Q2 FY23	Q/Q Change
Revenue	$871.3M	↑ 17.51%
Net Income	$115.9M	↑ 138.48%
Net Profit Margin	13.3%	↑ 6.75%

	Q3 FY23	Q/Q Change
Revenue	$975.0M	↑ 11.9%
Net Income	$120.7M	↑ 4.14%
Net Profit Margin	12.38%	↓ 0.92%

	Q4 FY23	Q/Q Change
Revenue	$1.0B	↑ 6.1%
Net Income	$256.3M	↑ 112.34%
Net Profit Margin	24.78%	↑ 12.4%

	Q1 FY24	Q/Q Change
Revenue	$921.0M	↓ 10.97%
Net Income	$146.4M	↓ 42.88%
Net Profit Margin	15.9%	↓ 8.88%

	Q2 FY24	Q/Q Change
Revenue	$1.0B	↑ 9.04%
Net Income	$143.5M	↓ 1.98%
Net Profit Margin	14.29%	↓ 1.61%

	Q3 FY24	Q/Q Change
Revenue	$994.2M	↓ 1.01%
Net Income	$134.6M	↓ 6.2%
Net Profit Margin	13.54%	↓ 0.75%

	FY18	Y/Y Change
Profit	$663.9M	↑ 34.91%

	FY19	Y/Y Change
Profit	$931.5M	↑ 40.31%

	FY20	Y/Y Change
Profit	$1.3B	↑ 37.42%

	FY21	Y/Y Change
Profit	$1.7B	↑ 31.28%

	FY22	Y/Y Change
Profit	$1.9B	↑ 12.06%

	FY23	Y/Y Change
Profit	$2.3B	↑ 21.55%

	Q2 FY23	Q/Q Change
Profit	$546.4M	↑ 18.12%

	Q3 FY23	Q/Q Change
Profit	$623.3M	↑ 14.07%

	Q4 FY23	Q/Q Change
Profit	$656.6M	↑ 5.34%

	Q1 FY24	Q/Q Change
Profit	$561.9M	↓ 14.42%

	Q2 FY24	Q/Q Change
Profit	$626.7M	↑ 11.53%

	Q3 FY24	Q/Q Change
Profit	$593.8M	↓ 5.25%

	FY18	Y/Y Change
Operating Cash Flow	$123.2M	↑ 33.91%
Investing Cash Flow	$-139.8M	↓ 3.19%
Financing Cash Flow	$710.4M	↑ 78.0%

	FY19	Y/Y Change
Operating Cash Flow	$314.5M	↑ 155.28%
Investing Cash Flow	$-1.0B	↑ 626.18%
Financing Cash Flow	$10.7M	↓ 98.49%

	FY20	Y/Y Change
Operating Cash Flow	$475.6M	↑ 51.22%
Investing Cash Flow	$-1.0B	↑ 0.28%
Financing Cash Flow	$912.1M	↑ 8424.3%

	FY21	Y/Y Change
Operating Cash Flow	$442.5M	↓ 6.96%
Investing Cash Flow	$-216.1M	↓ 78.77%
Financing Cash Flow	$10.4M	↓ 98.86%

	FY22	Y/Y Change
Operating Cash Flow	$669.5M	↑ 51.3%
Investing Cash Flow	$-521.5M	↑ 141.32%
Financing Cash Flow	$-552.5M	↓ 5412.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$190.3M	↑ 22.46%
Investing Cash Flow	$-555.9M	↑ 197.75%
Financing Cash Flow	$939.5M	↑ 8288.39%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$269.2M	↑ 41.46%
Investing Cash Flow	$-179.5M	↓ 67.71%
Financing Cash Flow	$-637.4M	↓ 167.84%

Dexcom Technicals Summary

Sell

Neutral

Buy

Dexcom is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Dexcom Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dexcom, Inc.	1.17%	-28.47%	-34.81%	-40.23%	46.3%
Stryker Corporation	-5.78%	9.1%	23.93%	37.28%	74.44%
Boston Scientific Corp.	0.25%	18.65%	56.74%	113.42%	100.0%
Edwards Lifesciences Corp.	7.26%	-16.18%	0.11%	-41.61%	-2.39%
Abbott Laboratories	-1.56%	11.42%	4.68%	-18.3%	32.25%
Medtronic Plc	-6.7%	4.69%	-2.54%	-21.95%	-29.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dexcom, Inc.	48.63	48.63	1.26	1.71	0.32	0.06	NA	5.07
Stryker Corporation	39.51	39.51	2.59	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	75.58	75.58	1.65	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	29.21	29.21	6.97	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.95	34.95	2.23	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.95	24.95	1.49	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dexcom, Inc.	Buy	$31.3B	46.3%	48.63	17.22%
Stryker Corporation	Buy	$140.8B	74.44%	39.51	16.34%
Boston Scientific Corp.	Buy	$134.8B	100.0%	75.58	11.26%
Edwards Lifesciences Corp.	Buy	$44.6B	-2.39%	29.21	65.86%
Abbott Laboratories	Buy	$199.4B	32.25%	34.95	13.99%
Medtronic Plc	Buy	$104.6B	-29.52%	24.95	12.06%

About Dexcom

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.

Organization	Dexcom
Employees	9500
CEO	Mr. Kevin Ronald Sayer
Industry	Health Technology

Management People of Dexcom

Name	Title
Mr. Kevin Ronald Sayer	Executive Chairman, CEO & President
Mr. Jereme M. Sylvain CPA	Executive VP, CFO & Chief Accounting Officer
Mr. Jacob Steven Leach	Executive VP & COO
Mr. Michael Jon Brown	Executive VP & Chief Legal Officer
Mr. Girish Naganathan	Executive VP & CTO
Mr. Sean Christensen	Director of Corporate Affairs & Head of Investor Relations
Mr. Matthew Dolan	Executive Vice President of Strategy, Corporate Development & Dexcom Labs
Ms. Leverne Marsh	Executive Vice President of Marketing
Ms. Sadie M. Stern	Executive VP & Chief Human Resources Officer
Mr. Donald M. Abbey	Executive Vice President of Global Business Services, Quality & Regulatory Affairs

Important FAQs about investing in Dexcom from India :

What is Dexcom share price today?

Dexcom share price today stands at $80.24, Open: $80.03 ; Previous Close: $80.57 ; High: $80.46 ; Low: $79.64 ; 52 Week High: $142.00 ; 52 Week Low: $62.34. The stock opens at $80.03, after a previous close of $80.57. The stock reached a daily high of $80.46 and a low of $79.64, with a 52-week high of $142.00 and a 52-week low of $62.34.

Can Indians buy Dexcom shares?

Yes, Indians can invest in the Dexcom (DXCM) from India.

With INDmoney, you can buy Dexcom at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dexcom at zero transaction cost.

How can I buy Dexcom shares from India?

It is very easy to buy Dexcom from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dexcom be purchased?

Yes, you can buy fractional shares of Dexcom with INDmoney app.

What are the documents required to start investing in Dexcom stocks?

To start investing in Dexcom, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.